Squarepoint
GOSS icon

Squarepoint’s Gossamer Bio GOSS Stock Holding History

Squarepoint’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Sell
2,556,378
-842,379
-25% -$235K ﹤0.01% 3554
2026
Q1 		$1.12M Buy
3,398,757
+3,177,166
+1,434% +$4.99M ﹤0.01% 2682
2025
Q4 		$687K Buy
+221,591
New +$632K ﹤0.01% 2935
2025
Q2 		– Sell
-217,921
Closed -$240K – 4694
2025
Q1 		$240K Buy
217,921
+145,977
+203% +$169K ﹤0.01% 3899
2024
Q4 		$65.1K Sell
71,944
-75,013
-51% -$64.3K ﹤0.01% 4798
2024
Q3 		$145K Buy
+146,957
New +$141K ﹤0.01% 3788
2024
Q2 		– Sell
-300,034
Closed -$354K – 4283
2024
Q1 		$354K Buy
300,034
+253,593
+546% +$279K ﹤0.01% 3280
2023
Q4 		$42.4K Buy
+46,441
New +$34.3K ﹤0.01% 3865
2023
Q3 		– Sell
-150,063
Closed -$180K – 3965
2023
Q2 		$180K Sell
150,063
-509,862
-77% -$635K ﹤0.01% 3255
2023
Q1 		$832K Sell
659,925
-255,001
-28% -$488K ﹤0.01% 2005
2022
Q4 		$1.99M Buy
914,926
+674,380
+280% +$5.55M 0.01% 1368
2022
Q3 		$2.88M Buy
240,546
+207,985
+639% +$2.58M 0.01% 1074
2022
Q2 		$273K Sell
32,561
-18,186
-36% -$141K ﹤0.01% 2328
2022
Q1 		$440K Buy
+50,747
New +$489K ﹤0.01% 2078
2021
Q3 		– Sell
-10,575
Closed -$86K – 3106
2021
Q2 		$86K Sell
10,575
-19,613
-65% -$170K ﹤0.01% 3042
2021
Q1 		$279K Sell
30,188
-23,929
-44% -$241K ﹤0.01% 2461
2020
Q4 		$523K Buy
54,117
+39,831
+279% +$392K ﹤0.01% 1786
2020
Q3 		$177K Buy
14,286
+393
+3% +$5.21K ﹤0.01% 2139
2020
Q2 		$181K Sell
13,893
-4,430
-24% -$55.7K ﹤0.01% 1847
2020
Q1 		$186K Sell
18,323
-15,114
-45% -$197K ﹤0.01% 1496
2019
Q4 		$523K Buy
+33,437
New +$673K ﹤0.01% 1753

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Squarepoint's GOSS Position: Q2 2026 in Review

Squarepoint reduced its Gossamer Bio (GOSS) stake by 25% in Q2 2026, selling an estimated $235K and leaving 2,556,378 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #3554.

Squarepoint first reported a position in GOSS in Q4 2019 and has held it in 21 quarters since. The position peaked at $2.88M in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Squarepoint held 2,556,378 shares of Gossamer Bio worth $421K as of Q2 2026.
  • Squarepoint sold 842,379 Gossamer Bio shares in Q2 2026, an estimated $235K.
  • Gossamer Bio made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3554 holding.
  • Squarepoint first reported a position in Gossamer Bio in Q4 2019 and has held it in 21 quarters since.
  • Squarepoint's Gossamer Bio position peaked at $2.88M in Q3 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.